Multi–Detector Row CT of Pancreatic Islet Cell Tumors1

Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland, United States
Radiographics (Impact Factor: 2.6). 03/2006; 26(2):453-64. DOI: 10.1148/rg.262055056
Source: PubMed

ABSTRACT Pancreatic islet cell tumors (ICTs) are neuroendocrine neoplasms that produce and secrete hormones to a variable degree. These neoplasms can present a diagnostic challenge, both clinically and radiologically. ICTs can be classified as either syndromic or nonsyndromic on the basis of their clinical manifestations. Multi-detector row computed tomography (CT) plays an important role in the diagnosis and staging of both syndromic and nonsyndromic ICTs. In general, syndromic ICTs are less than 3 cm in size. They are typically hyperenhancing and are usually best seen on CT scans obtained during the arterial phase. Nonsyndromic ICTs tend to be larger than syndromic ICTs at presentation and are more likely to be cystic or necrotic. It is important for the radiologist to be familiar with appropriate CT protocol for the evaluation of patients with suspected pancreatic ICT and to understand the variable CT appearances of these neoplasms.

7 Reads
  • Source
    • "In general, islet cell tumours are hyperenhancing and may be within the gland or exophytic [39] (Fig. 10). These lesions lack the desmoplastic reaction seen in ductal adenocarcinoma and so rarely cause pancreatic duct dilatation or obstruction [36]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The pancreas is a site of origin of a diverse range of benign and malignant tumours, and these are frequently detected, diagnosed and staged with computed tomography (CT). Knowledge of the typical appearance of these neoplasms as well as the features of locoregional invasion is fundamental for all general and abdominal radiologists. This pictorial essay aims to outline the characteristic CT appearances of the spectrum of pancreatic neoplasms, as well as important demographic and clinical information that aids diagnosis. The second article in this series addresses common mimics of pancreatic neoplasia.
    Insights into Imaging 08/2011; 2(4):379-388. DOI:10.1007/s13244-011-0102-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: This chapter reviews the clinical, macroscopic, and microscopic features, as well as the differential diagnosis of the most common pancreas lesions seen in a routine surgical pathology practice. It begins with the main congenital anomalies and metabolic disorders and then proceeds to the inflammatory conditions including acute and chronic pancreatitis and their subtypes. The neoplasia section begins with ductal neoplasia including the most common neoplasm of the pancreas, invasive ductal carcinoma, and other carcinomas of ductal origin. This is followed by a discussion of preinvasive ductal neoplasia and serous cystic neoplasms. The nonductal neoplasia section covers acinar cell carcinoma, endocrine neoplasia, solid pseudopapillary neoplasm, and pancreatoblastoma. Miscellaneous tumors and cystic lesions are also covered. Finally, quick review of how to report pancreatic tumors and the TNM classification of pancreatic tumors are presented.
    Gastroenterology 05/1962; 42:481-96. DOI:10.1007/978-1-4419-6043-6_43 · 16.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neuroendocrine tumors (NETs) are rare and represent a diverse collection of malignancies that occur in many organ systems throughout the body, including the gastrointestinal and respiratory tracts. Unfortunately, the majority of patients with NETs have hepatic metastases at the time of diagnosis. Although some patients may be asymptomatic, others have unusual clinical presentations and variable tumor growth patterns. Although many patients have long indolent courses, without treatment, most patients die within 5 years of diagnosis. This article reviews the care of patients with NETs and hepatic metastases, with emphasis on the increasingly important role of oncologic image-guided interventions.
    Journal of Vascular and Interventional Radiology 09/2006; 17(8):1235-49; quiz 1250. DOI:10.1097/01.RVI.0000232177.57950.71 · 2.41 Impact Factor
Show more


7 Reads
Available from